Risk of Post-COVID-19 Conditions Among Adolescents and Adults Who Received Nirmatrelvir-Ritonavir for Acute COVID-19: A Retrospective Cohort Study
Dalton et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofaf567 (preprint 5/31/2025)
https://c19early.org/dalton2.html